Wu H, Han Z, Wu J, Zhang Y, et al. CD39 and PD-L1 co-expression may serve as potential indicators for evaluating the efficacy of neoadjuvant immunotherapy in esophageal squamous cell carcinoma. Dis Esophagus 2026;39:doag063.
PMID: 42372291